MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
CONMED Corporation DIO Ratio 2011-2025 | CNMD
Annual DIO Ratio CONMED Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 211 | 209 | 217 | 176 | 163 | 140 | 144 | 141 | 140 | 181 | 161 | 149 | 158 | 176 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 217 | 140 | 169 |
Quarterly DIO Ratio CONMED Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 193 | 212 | 222 | 220 | 198 | 211 | 218 | 206 | 217 | - | 113 | 92.3 | 208 | - | 188 | 167 | 175 | - | 171 | 207 | 173 | - | 145 | 140 | 150 | - | 154 | 146 | 146 | - | 147 | 140 | 146 | - | 148 | 136 | 147 | - | 201 | 174 | 168 | - | 172 | 155 | 168 | - | 156 | 145 | 162 | - | 170 | 158 | 159 | - | 189 | 167 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 222 | 92.3 | 170 |
DIO Ratio of other stocks in the Medical devices industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
75.1 | - | - | $ 1.77 B |  USA |
 |
Abiomed
ABMD
|
193 | - | - | $ 17.2 B | USA |
 |
Acutus Medical
AFIB
|
108 | - | -26.83 % | $ 2.62 M | USA |
 |
Lianluo Smart Limited
LLIT
|
50 | - | 24.59 % | $ 44.8 M |  China |
 |
Apyx Medical Corporation
APYX
|
213 | $ 3.83 | -0.91 % | $ 133 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
240 | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
237 | $ 304.01 | -1.34 % | $ 8.58 B | USA |
 |
Apollo Endosurgery
APEN
|
160 | - | - | $ 475 M | USA |
 |
BioSig Technologies
BSGM
|
7.1 K | - | 37.08 % | $ 85.7 M | USA |
 |
InMode Ltd.
INMD
|
246 | $ 14.41 | -0.69 % | $ 1.14 B |  Israel |
 |
IRIDEX Corporation
IRIX
|
125 | $ 0.95 | 3.18 % | $ 15.3 M | USA |
 |
IRadimed Corporation
IRMD
|
251 | $ 96.59 | 0.37 % | $ 1.22 B | USA |
 |
Bruker Corporation
BRKR
|
216 | $ 45.43 | 0.66 % | $ 6.77 K | USA |
 |
Allied Healthcare Products
AHPI
|
133 | - | 3.58 % | $ 2.21 M | USA |
 |
Abbott Laboratories
ABT
|
125 | $ 128.4 | 2.34 % | $ 223 B | USA |
 |
Boston Scientific Corporation
BSX
|
184 | $ 92.29 | -0.31 % | $ 136 B | USA |
 |
Conformis
CFMS
|
160 | - | - | $ 16.4 M | USA |
 |
CryoLife, Inc.
CRY
|
312 | - | -4.14 % | $ 702 M | USA |
 |
LivaNova PLC
LIVN
|
141 | $ 62.5 | -0.4 % | $ 3.39 B |  Britain |
 |
EDAP TMS S.A.
EDAP
|
163 | $ 2.94 | 2.08 % | $ 110 M |  France |
 |
LENSAR
LNSR
|
179 | $ 11.57 | 0.52 % | $ 133 M | USA |
 |
Cardiovascular Systems
CSII
|
192 | - | 0.15 % | $ 844 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
247 | - | 1.15 % | $ 34.5 M | USA |
 |
Cutera
CUTR
|
135 | - | -10.19 % | $ 1.99 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
212 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
272 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
10.1 | - | - | $ 111 M |  Canada |
 |
Eargo
EAR
|
85.3 | - | - | $ 10.2 M | USA |
 |
Dynatronics Corporation
DYNT
|
91.1 | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
145 | - | - | $ 955 M | USA |
|
Cognyte Software Ltd.
CGNT
|
76.7 | $ 9.66 | -2.03 % | $ 694 M | Israel |
 |
PAVmed
PAVM
|
11.1 | $ 0.32 | -3.03 % | $ 2.31 M | USA |
 |
Second Sight Medical Products
EYES
|
175 | - | -0.97 % | $ 54.4 M | USA |
 |
Align Technology
ALGN
|
83.8 | $ 164.01 | -0.86 % | $ 12.3 B | USA |
 |
Accuray Incorporated
ARAY
|
164 | $ 1.06 | -0.09 % | $ 109 M | USA |
 |
Quanterix Corporation
QTRX
|
138 | $ 7.38 | -2.38 % | $ 277 M | USA |
 |
Avinger
AVGR
|
332 | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
220 | $ 12.57 | -1.1 % | $ 340 M | USA |
 |
FONAR Corporation
FONR
|
13.9 | $ 14.63 | -0.81 % | $ 95.9 M | USA |
 |
AxoGen
AXGN
|
226 | $ 30.14 | -0.82 % | $ 1.33 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
290 | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
143 | - | -0.57 % | $ 7.12 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
725 | $ 17.75 | 0.82 % | $ 410 M | USA |
 |
Globus Medical
GMED
|
266 | $ 86.64 | -0.06 % | $ 11.8 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
205 | $ 13.61 | 1.42 % | $ 1.05 B | USA |
 |
Aziyo Biologics
AZYO
|
108 | - | 1.37 % | $ 20.5 M | USA |